The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Physiotherapists can help implement physical activity programmes in clinical practice

(2014) Brendon Stubbs et al.   BRITISH JOURNAL OF PSYCHIATRY

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

(2014) Maarten Bak et al.   PLoS One

Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis

(2014) Shanhu Qiu et al.   PLoS One

Long-term mortality of persons with severe mental illness and diabetes: a population-based cohort study in Denmark

(2014) A. R. Ribe et al.   PSYCHOLOGICAL MEDICINE

Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort

(2014) Ulrich Reininghaus et al.   SCHIZOPHRENIA BULLETIN

Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis

(2014) Debra L. Foley et al.   World Psychiatry

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders

(2014) Christoph U. Correll et al.   JAMA Psychiatry

Effects of exercise training on quality of life, symptoms of depression, symptoms of anxiety and emotional well-being in type 2 diabetes mellitus: a systematic review

(2013) M. M. P. van der Heijden et al.   DIABETOLOGIA

Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions

(2013) Dieter Schoepf et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

(2013) Davy Vancampfort et al.   World Psychiatry

The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers

(2013) D. Lawrence et al.   BMJ-British Medical Journal

Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis

(2012) E. G. Wilmot et al.   DIABETOLOGIA

Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs

(2012) Peter Manu et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia

(2012) Nancy E. Morden et al.   GENERAL HOSPITAL PSYCHIATRY

Mental illness related disparities in diabetes prevalence, quality of care and outcomes: a population-based longitudinal study

(2011) Qun Mai et al.   BMC Medicine

Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up

(2011) D. Schoepf et al.   EUROPEAN PSYCHIATRY

Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms

(2011) Roberto Nuevo et al.   JOURNAL OF CLINICAL PSYCHIATRY

Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104)

(2011) V Mohan et al.   Journal of Postgraduate Medicine

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

(2011) A. J. Mitchell et al.   PSYCHOLOGICAL MEDICINE

Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis

(2011) Alex J. Mitchell et al.   SCHIZOPHRENIA BULLETIN

Cardiovascular risk in a first-episode psychosis sample: A ‘critical period’ for prevention?

(2011) Vivek H. Phutane et al.   SCHIZOPHRENIA RESEARCH

Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia

(2010) L.C. Bresee et al.   EUROPEAN PSYCHIATRY

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Is Abnormal Glucose Tolerance in Antipsychotic-Naive Patients With Nonaffective Psychosis Confounded by Poor Health Habits?

(2010) B. Kirkpatrick et al.   SCHIZOPHRENIA BULLETIN

Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: A nationwide retrospective cohort study

(2010) Yasuyuki Okumura et al.   SCHIZOPHRENIA RESEARCH

Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study

(2010) Lauren C. Bresee et al.   SCHIZOPHRENIA RESEARCH

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis

(2009) Swapna K. Verma et al.   JOURNAL OF CLINICAL PSYCHIATRY

Prevalence of diabetes in patients with schizophrenia in Taiwan: A population-based National Health Insurance study

(2009) I-Chia Chien et al.   SCHIZOPHRENIA RESEARCH